MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 582062 | Name: Prednylidene

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Prednylidene is a biochemical.

Chemical Structure

Prednylidene
CAS#599-33-7

Theoretical Analysis

MedKoo Cat#: 582062

Name: Prednylidene

CAS#: 599-33-7

Chemical Formula: C22H28O5

Exact Mass: 372.1900

Molecular Weight: 372.46

Elemental Analysis: C, 70.94; H, 7.58; O, 21.48

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Prednylidene; 16-Methyleneprednisolone; Dacorsol; Decortilen; Prednilideno; Prednylidenum; ST104; UNII-IF8PQP966U.
IUPAC/Chemical Name
11beta,17,21-Trihydroxy-16-methylenepregna-1,4-diene-3,20-dione
InChi Key
WSVOMANDJDYYEY-CWNVBEKCSA-N
InChi Code
InChI=1S/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-20(13,2)19(15)17(25)10-21(16,3)22(12,27)18(26)11-23/h6-7,9,15-17,19,23,25,27H,1,4-5,8,10-11H2,2-3H3/t15-,16-,17-,19+,20-,21-,22-/m0/s1
SMILES Code
C[C@]1([C@](C2)([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3([H])[C@@H](O)C1)=O)[C@](C(CO)=O)(O)C2=C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 372.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Shar PA, Tao W, Gao S, Huang C, Li B, Zhang W, Shahen M, Zheng C, Bai Y, Wang Y. Pred-binding: large-scale protein-ligand binding affinity prediction. J Enzyme Inhib Med Chem. 2016 Dec;31(6):1443-50. doi: 10.3109/14756366.2016.1144594. Epub 2016 Feb 18. PubMed PMID: 26888050. 2: Georgiou GK, Gizas I, Katopodis KP, Katsios CS. Non-secreting benign glucagonoma diagnosed incidentally in a patient with refractory thrombocytopenic thrombotic purpura: report of a case. Surg Today. 2015 Oct;45(10):1317-20. doi: 10.1007/s00595-014-1073-3. Epub 2014 Nov 6. PubMed PMID: 25373364. 3: Sato Y, Yamauchi A, Urano M, Kondo E, Saito K. Corticosteroid therapy for duchenne muscular dystrophy: improvement of psychomotor function. Pediatr Neurol. 2014 Jan;50(1):31-7. doi: 10.1016/j.pediatrneurol.2013.07.022. Epub 2013 Oct 15. PubMed PMID: 24138948. 4: Kaneko T, Arima R, Arakawa Y, Aoki M, Fukuda K, Fukui M, Hirama A, Fujita E, Mii A, Utsumi K, Shimizu A, Iino Y. [Two cases of rapidly progressive nephritic syndrome complicated with alcoholic liver cirrhosis]. Nihon Jinzo Gakkai Shi. 2011;53(1):60-7. Japanese. PubMed PMID: 21370579. 5: Zimmer C, Beiderlinden M, Peters J. Lethal acute respiratory distress syndrome during anti-TNF-alpha therapy for rheumatoid arthritis. Clin Rheumatol. 2006 May;25(3):430-2. Epub 2005 Oct 1. PubMed PMID: 16200383. 6: Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AF, Diederich S, Bahr V. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol. 2004 Sep;151(3):397-406. PubMed PMID: 15362971. 7: Diederich S, Eigendorff E, Burkhardt P, Quinkler M, Bumke-Vogt C, Rochel M, Seidelmann D, Esperling P, Oelkers W, Bähr V. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids. J Clin Endocrinol Metab. 2002 Dec;87(12):5695-701. PubMed PMID: 12466373. 8: Schmid D, Burmester GR, Tripmacher R, Kuhnke A, Buttgereit F. Bioenergetics of human peripheral blood mononuclear cell metabolism in quiescent, activated, and glucocorticoid-treated states. Biosci Rep. 2000 Aug;20(4):289-302. PubMed PMID: 11092251. 9: Buttgereit F, Brand MD, Burmester GR. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol. 1999 Jul 15;58(2):363-8. PubMed PMID: 10423179. 10: Berthold A, Cremer K, Kreuter J. Collagen microparticles: carriers for glucocorticosteroids. Eur J Pharm Biopharm. 1998 Jan;45(1):23-9. PubMed PMID: 9689532. 11: Zwadlo-Klarwasser G, Hamann W, Gatsios P, Graeve L, Schmutzler W. Expression of interleukin-6 receptor subunits in human macrophage subsets. Int Arch Allergy Immunol. 1997 May-Jul;113(1-3):300-1. PubMed PMID: 9130557. 12: Winkler M, Heyl W, Reister F, Rath W. [Does lung maturation therapy with 16-methylene-prednisolone modify maternal infection parameters in threatened premature labor?]. Geburtshilfe Frauenheilkd. 1996 Jun;56(6):317-21. German. PubMed PMID: 8766490. 13: Röckelein S, Gebert M, Baar H, Endsberger G. [Neuromuscular blockade with atracurium in dermatomyositis]. Anaesthesist. 1995 Jun;44(6):442-4. German. PubMed PMID: 7653797. 14: Zwadlo-Klarwasser G, Hamann W, Flöter A, Schmutzler W. New anti-inflammatory proteins secreted by human glucocorticoid-treated macrophages. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):430-1. PubMed PMID: 7613202. 15: Hauptmann S, Bernauer J, Zwadlo-Klarwasser G, Klosterhalfen B, Kirkpatrick CJ. Differential adherence of the human monocyte subsets 27E10 and RM3/1 to cytokine- or glucocorticoid-treated endothelial cells. Pathobiology. 1994;62(5-6):262-8. PubMed PMID: 7598795. 16: Zwadlo-Klarwasser G, Bent S, Haubeck HD, Sorg C, Schmutzler W. Glucocorticoid-induced appearance of the macrophage subtype RM 3/1 in peripheral blood of man. Int Arch Allergy Appl Immunol. 1990;91(2):175-80. PubMed PMID: 2341198. 17: Hammann KP, Ruf P, Hopf HC. The inhibitory effects of prednisone, 16-methylen-prednisolone, and ACTH on con-A induced lymphokines (interferon-y) as measured by the chemiluminescence-activity of blood monocytes. Immunopharmacol Immunotoxicol. 1988;10(4):463-78. PubMed PMID: 2854542. 18: Budde R, Schaefer HE. [Cytochemical differentiation of T- and B-lymphocytes in the short-tailed mouse (Clethrionomys glareolus)]. Acta Histochem Suppl. 1985;31:83-105. German. PubMed PMID: 3927411. 19: Dwenger A, Holle W, Zick R, Trautschold I. Insulin binding to erythrocytes after acute 16-methyleneprednisolone ingestion. J Clin Chem Clin Biochem. 1982 Oct;20(10):731-4. PubMed PMID: 6754851. 20: SIMONNET H, BOURGOIS R. [ON THE DIURETIC ACTION OF 16-METHYLENEPREDNISOLONE (ST 104)]. Therapie. 1964 Sep-Oct;19:1375-84. French. PubMed PMID: 14227797.